Brief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
BRIEF-Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award Sept 1 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO:
CIPHER PHARMACEUTICALS RECEIVES FAVOURABLE DECISION CONFIRMING ARBITRATION AWARD
CIPHER PHARMACEUTICALS - COURT DENIES SUN PETITION AND CONFIRMS ARBITRATION AWARD IN FAVOUR OF CIPHER
CIPHER PHARMACEUTICALS - AWARDED 15% ROYALTY ON ABSORICA LD SALES IN CANADA FROM 2026 TO 2040
CIPHER PHARMACEUTICALS - COURT AWARDS CIPHER INTEREST ON DAMAGES AND LEGAL FEES AT 9% PER ANNUM
CIPHER PHARMACEUTICALS - INTENDS TO PURSUE CLAIMS AGAINST SUN IN OTHER JURISDICTIONS
CIPHER PHARMACEUTICALS - COURT AWARDS CIPHER ADDITIONAL INTEREST UNTIL JUDGMENT IS SATISFIED
Source text: ID:nCNW758Xfa
Further company coverage: CPH.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sun Pharmaceutical Industries
See all newsROI-US blue wave reshapes Asia's winners and losers: Manishi Raychaudhuri
Brief: Sun Pharma Clarifies Regarding News Report Relating To Company's Assam Facility
Street View: India's Sun Pharma Organon buy, psoriasis drug are risk factors
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses